THE MYASTHENIC SYNDROME: ANAESTHESIA IN A PATIENT TREATED WITH 3.4 DIAMINOPYRIDINE

A case of anaesthesia in a patient with myasthenic syndrome treated with 3.4 diamino-pyridine is described. Despite symptomatic improvement and an improved electromyogram (EMG) on treatment, extreme sensitivity to neuromuscular block occurred with vecuronium. Antagonism of block was poor with an ant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of anaesthesia : BJA 1990-03, Vol.64 (3), p.363-366
Hauptverfasser: TELFORD, R.J., HOLLWAY, T.E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 366
container_issue 3
container_start_page 363
container_title British journal of anaesthesia : BJA
container_volume 64
creator TELFORD, R.J.
HOLLWAY, T.E.
description A case of anaesthesia in a patient with myasthenic syndrome treated with 3.4 diamino-pyridine is described. Despite symptomatic improvement and an improved electromyogram (EMG) on treatment, extreme sensitivity to neuromuscular block occurred with vecuronium. Antagonism of block was poor with an anti-cholinesterase, while oral 3.4 diaminopyridine improved neuromuscular transmission further. A combination of anticholinesterase with amino-pyridine may be the antagonistic combination of choice in this condition.
doi_str_mv 10.1093/bja/64.3.363
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79728923</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000709121738649X</els_id><sourcerecordid>79728923</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-84de144ded3410db2de19a53bb030b96a3d3fb93bdef7a4d50bd66d6867717183</originalsourceid><addsrcrecordid>eNptkEtLAzEQgIMoWh83r0IO4smtySZNNt5Cu9qA3Uq7Ij2FZJOFlb7ctIL_3pQWvXiZYWY-ZpgPgGuMuhgJ8mA_zAOjXdIljByBDqYcJ4xzfAw6CCGeIIHTM3AewgdCmKeidwpOseAoZaQDJuUwh6OZnMZcqD6czorBZDzKH6EsZL7rTpWEqoASvspS5UUJy0kuy3wA31U5hKRL4UDJkSrGr7OJGqgivwQntZkHf3XIF-DtKS_7w-Rl_Kz68iWpKEKbJKPOYxqDIxQjZ9NYCtMj1iKCrGCGOFJbQazzNTfU9ZB1jDmW7X7jOCMX4G6_d92uPrc-bPSiCZWfz83Sr7ZBc8HTTKQkgvd7sGpXIbS-1uu2WZj2W2Okdwp1VKgZ1URHhRG_Oezd2oV3f_DeWZzfHuYmVGZet2ZZNeEXY5ngROwwtsd8dPDV-FaHqvHLyrum9dVGu1Xz__0fifWDmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79728923</pqid></control><display><type>article</type><title>THE MYASTHENIC SYNDROME: ANAESTHESIA IN A PATIENT TREATED WITH 3.4 DIAMINOPYRIDINE</title><source>MEDLINE</source><source>Oxford journals</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>TELFORD, R.J. ; HOLLWAY, T.E.</creator><creatorcontrib>TELFORD, R.J. ; HOLLWAY, T.E.</creatorcontrib><description>A case of anaesthesia in a patient with myasthenic syndrome treated with 3.4 diamino-pyridine is described. Despite symptomatic improvement and an improved electromyogram (EMG) on treatment, extreme sensitivity to neuromuscular block occurred with vecuronium. Antagonism of block was poor with an anti-cholinesterase, while oral 3.4 diaminopyridine improved neuromuscular transmission further. A combination of anticholinesterase with amino-pyridine may be the antagonistic combination of choice in this condition.</description><identifier>ISSN: 0007-0912</identifier><identifier>EISSN: 1471-6771</identifier><identifier>DOI: 10.1093/bja/64.3.363</identifier><identifier>PMID: 1970263</identifier><identifier>CODEN: BJANAD</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>4-Aminopyridine - analogs &amp; derivatives ; 4-Aminopyridine - pharmacology ; 4-Aminopyridine - therapeutic use ; Aged ; Amifampridine ; Anesthesia, General ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Glycopyrrolate - pharmacology ; Humans ; Lambert-Eaton Myasthenic Syndrome - drug therapy ; Male ; Medical sciences ; Myasthenic syndrome: 3.4 diaminopytidine ; Neostigmine - pharmacology ; Neuropharmacology ; Pharmacology. Drug treatments ; Potassium Channels - drug effects ; Vecuronium Bromide - antagonists &amp; inhibitors ; Vecuronium Bromide - pharmacology</subject><ispartof>British journal of anaesthesia : BJA, 1990-03, Vol.64 (3), p.363-366</ispartof><rights>1990</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-84de144ded3410db2de19a53bb030b96a3d3fb93bdef7a4d50bd66d6867717183</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6897393$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1970263$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TELFORD, R.J.</creatorcontrib><creatorcontrib>HOLLWAY, T.E.</creatorcontrib><title>THE MYASTHENIC SYNDROME: ANAESTHESIA IN A PATIENT TREATED WITH 3.4 DIAMINOPYRIDINE</title><title>British journal of anaesthesia : BJA</title><addtitle>Br J Anaesth</addtitle><description>A case of anaesthesia in a patient with myasthenic syndrome treated with 3.4 diamino-pyridine is described. Despite symptomatic improvement and an improved electromyogram (EMG) on treatment, extreme sensitivity to neuromuscular block occurred with vecuronium. Antagonism of block was poor with an anti-cholinesterase, while oral 3.4 diaminopyridine improved neuromuscular transmission further. A combination of anticholinesterase with amino-pyridine may be the antagonistic combination of choice in this condition.</description><subject>4-Aminopyridine - analogs &amp; derivatives</subject><subject>4-Aminopyridine - pharmacology</subject><subject>4-Aminopyridine - therapeutic use</subject><subject>Aged</subject><subject>Amifampridine</subject><subject>Anesthesia, General</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Glycopyrrolate - pharmacology</subject><subject>Humans</subject><subject>Lambert-Eaton Myasthenic Syndrome - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myasthenic syndrome: 3.4 diaminopytidine</subject><subject>Neostigmine - pharmacology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium Channels - drug effects</subject><subject>Vecuronium Bromide - antagonists &amp; inhibitors</subject><subject>Vecuronium Bromide - pharmacology</subject><issn>0007-0912</issn><issn>1471-6771</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkEtLAzEQgIMoWh83r0IO4smtySZNNt5Cu9qA3Uq7Ij2FZJOFlb7ctIL_3pQWvXiZYWY-ZpgPgGuMuhgJ8mA_zAOjXdIljByBDqYcJ4xzfAw6CCGeIIHTM3AewgdCmKeidwpOseAoZaQDJuUwh6OZnMZcqD6czorBZDzKH6EsZL7rTpWEqoASvspS5UUJy0kuy3wA31U5hKRL4UDJkSrGr7OJGqgivwQntZkHf3XIF-DtKS_7w-Rl_Kz68iWpKEKbJKPOYxqDIxQjZ9NYCtMj1iKCrGCGOFJbQazzNTfU9ZB1jDmW7X7jOCMX4G6_d92uPrc-bPSiCZWfz83Sr7ZBc8HTTKQkgvd7sGpXIbS-1uu2WZj2W2Okdwp1VKgZ1URHhRG_Oezd2oV3f_DeWZzfHuYmVGZet2ZZNeEXY5ngROwwtsd8dPDV-FaHqvHLyrum9dVGu1Xz__0fifWDmA</recordid><startdate>19900301</startdate><enddate>19900301</enddate><creator>TELFORD, R.J.</creator><creator>HOLLWAY, T.E.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19900301</creationdate><title>THE MYASTHENIC SYNDROME: ANAESTHESIA IN A PATIENT TREATED WITH 3.4 DIAMINOPYRIDINE</title><author>TELFORD, R.J. ; HOLLWAY, T.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-84de144ded3410db2de19a53bb030b96a3d3fb93bdef7a4d50bd66d6867717183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>4-Aminopyridine - analogs &amp; derivatives</topic><topic>4-Aminopyridine - pharmacology</topic><topic>4-Aminopyridine - therapeutic use</topic><topic>Aged</topic><topic>Amifampridine</topic><topic>Anesthesia, General</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Glycopyrrolate - pharmacology</topic><topic>Humans</topic><topic>Lambert-Eaton Myasthenic Syndrome - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myasthenic syndrome: 3.4 diaminopytidine</topic><topic>Neostigmine - pharmacology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium Channels - drug effects</topic><topic>Vecuronium Bromide - antagonists &amp; inhibitors</topic><topic>Vecuronium Bromide - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TELFORD, R.J.</creatorcontrib><creatorcontrib>HOLLWAY, T.E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of anaesthesia : BJA</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TELFORD, R.J.</au><au>HOLLWAY, T.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE MYASTHENIC SYNDROME: ANAESTHESIA IN A PATIENT TREATED WITH 3.4 DIAMINOPYRIDINE</atitle><jtitle>British journal of anaesthesia : BJA</jtitle><addtitle>Br J Anaesth</addtitle><date>1990-03-01</date><risdate>1990</risdate><volume>64</volume><issue>3</issue><spage>363</spage><epage>366</epage><pages>363-366</pages><issn>0007-0912</issn><eissn>1471-6771</eissn><coden>BJANAD</coden><abstract>A case of anaesthesia in a patient with myasthenic syndrome treated with 3.4 diamino-pyridine is described. Despite symptomatic improvement and an improved electromyogram (EMG) on treatment, extreme sensitivity to neuromuscular block occurred with vecuronium. Antagonism of block was poor with an anti-cholinesterase, while oral 3.4 diaminopyridine improved neuromuscular transmission further. A combination of anticholinesterase with amino-pyridine may be the antagonistic combination of choice in this condition.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>1970263</pmid><doi>10.1093/bja/64.3.363</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0912
ispartof British journal of anaesthesia : BJA, 1990-03, Vol.64 (3), p.363-366
issn 0007-0912
1471-6771
language eng
recordid cdi_proquest_miscellaneous_79728923
source MEDLINE; Oxford journals; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects 4-Aminopyridine - analogs & derivatives
4-Aminopyridine - pharmacology
4-Aminopyridine - therapeutic use
Aged
Amifampridine
Anesthesia, General
Anesthetics. Neuromuscular blocking agents
Biological and medical sciences
Glycopyrrolate - pharmacology
Humans
Lambert-Eaton Myasthenic Syndrome - drug therapy
Male
Medical sciences
Myasthenic syndrome: 3.4 diaminopytidine
Neostigmine - pharmacology
Neuropharmacology
Pharmacology. Drug treatments
Potassium Channels - drug effects
Vecuronium Bromide - antagonists & inhibitors
Vecuronium Bromide - pharmacology
title THE MYASTHENIC SYNDROME: ANAESTHESIA IN A PATIENT TREATED WITH 3.4 DIAMINOPYRIDINE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T08%3A51%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20MYASTHENIC%20SYNDROME:%20ANAESTHESIA%20IN%20A%20PATIENT%20TREATED%20WITH%203.4%20DIAMINOPYRIDINE&rft.jtitle=British%20journal%20of%20anaesthesia%20:%20BJA&rft.au=TELFORD,%20R.J.&rft.date=1990-03-01&rft.volume=64&rft.issue=3&rft.spage=363&rft.epage=366&rft.pages=363-366&rft.issn=0007-0912&rft.eissn=1471-6771&rft.coden=BJANAD&rft_id=info:doi/10.1093/bja/64.3.363&rft_dat=%3Cproquest_cross%3E79728923%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79728923&rft_id=info:pmid/1970263&rft_els_id=S000709121738649X&rfr_iscdi=true